Chemical Compound

Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester, calcium salt (1:1); Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) (9CI); Fosamprenavir calcium; GW 433908G; Lexiva; GW 433908G; fosamprenavir calcium pentahydrate

CAS Registry Number 226700-81-8
返回搜索 申请报价
Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester, calcium salt (1:1); Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) (9CI); Fosamprenavir calcium; GW 433908G; Lexiva; GW 433908G; fosamprenavir calcium pentahydrate 结构式
Primary record

Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester, calcium salt (1:1); Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) (9CI); Fosamprenavir calcium; GW 433908G; Lexiva; GW 433908G; fosamprenavir calcium pentahydrate

库存
3,255 克
纯度
99.5 %
CAS
226700-81-8

化合物标识与属性

CAS
226700-81-8
PubChem CID
131535
SMILES
CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2]
Canonical SMILES
CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Ca+2]

名称与同义词

  • Fosamprenavir calcium
  • Lexiva
  • Fosamprenavir Calcium Salt
  • Telzir
  • 226700-81-8
  • Fosamprenavircalcium
  • Lexiva (TN)
  • Telzir (TN)
  • Fosamprenavir calcium [USAN]
  • Amprenavir phosphate calcium
  • Fosamprenavir (Calcium Salt)
  • RefChem:55231
  • AC1L2ZCL
  • ID1GU2627N
  • UNII-ID1GU2627N
  • DTXSID0046777
  • C25H34CaN3O9PS
  • GW 433908G
  • GW433908G
  • C25H36N3O9PS.Ca
  • DTXCID8026777
  • Fosamprenavir calcium (USAN)
  • MLS006012033
  • GW-433908G
  • orb1685412
  • SCHEMBL1649283
  • CHEMBL1200734
  • EX-A6824A
  • AMY6787
  • MFCD08141843
  • PMDQGYMGQKTCSX-HQROKSDRSA-L
  • 226700-81-8 (calcium)
  • Tox21_112632
  • CID131535
  • HY-17431R
  • VX-175
  • FOSAMPRENAVIR CALCIUM [MART.]
  • AKOS015950832
  • C25-H36-N3-O9-P-S.Ca
  • FOSAMPRENAVIR CALCIUM [WHO-DD]
  • CS-1411
  • EBC-102105
  • FOSAMPRENAVIR CALCIUM SALT [MI]
  • FOSAMPRENAVIR CALCIUM [EMA EPAR]
  • Fosamprenavir calcium, >=98% (HPLC)
  • Fosamprenavir (Calcium Salt) (Standard)
  • NCGC00168771-01
  • AC-37657
  • AN-16772
  • AS-82030
  • DA-73529
  • HY-17431
  • SMR004703563
  • SY114803
  • FOSAMPRENAVIR CALCIUM [ORANGE BOOK]
  • AB1004608
  • GW-433908
  • LS-186584
  • ST2419393
  • CAS-226700-81-8
  • Z4451
  • C74170
  • D03835
  • SBI-0654638.0001
  • A855875
  • Q27280661
  • Calcium (2R,3S)-1-(4-amino-N-isobutylphenylsulfonamido)-4-phenyl-3-(((((S)-tetrahydrofuran-3-yl)oxy)carbonyl)amino)butan-2-yl phosphate
  • calcium;[(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate
  • ((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-benzyl-2-(phosphonooxy)propyl)carboxamide calcium salt
  • Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt (1:1)
  • (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R)-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1)
  • Calcium [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonatooxy-butan-2-yl]carbamate
  • Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt
  • (3S)-TETRAHYDRO-3-FURYL ((.ALPHA.S)-.ALPHA.-((1R)-1-HYDROXY-2-(N(SUP 1)-ISOBUTYLSULFANILAMIDO)ETHYL)PHENETHYL)CARBAMATE, CALCIUM PHOSPHATE (ESTER) (1:1)
  • (3S)-Tetrahydro-3-furyl [(alphaS)-alpha-[(1R)-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate, calcium phosphate (ester) (1:1)
  • Calcium (2R,3S)-1-(4-Amino-N-isobutylphenylsulfonamido)-4-phenyl-3-[[[[(S)-tetrahydrofuran-3-yl]oxy]carbonyl]amino]-2-butyl Phosphate
  • Calcium (2R,3S)-1-[4-amino-N-(2-methylpropyl)benzene-1-sulfonamido]-3-[({[(3S)-oxolan-3-yl]oxy}carbonyl)amino]-4-phenylbutan-2-yl phosphate
  • calcium [(1R,2S)-1-[[(4-aminophenyl)sulfonyl-isobutyl-amino]methyl]-3-phenyl-2-[[(3S)-tetrahydrofuran-3-yl]oxycarbonylamino]propyl] phosphate
  • calcium [(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate
  • Calcium(2R,3S)-1-(4-amino-N-isobutylphenylsulfonamido)-4-phenyl-3-(((((S)-tetrahydrofuran-3-yl)oxy)carbonyl)amino)butan-2-ylphosphate
  • Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester, calcium salt (1:1); Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) (9CI); Fosamprenavir calcium; GW 433908G; Lexiva; GW 433908G; fosamprenavir calcium pentahydrate